The cancer wounds treatment market is projected to grow from USD 2,851.0 million in 2026 to USD 5,930.9 million by 2036, at a CAGR of 7.6%. Advanced & antimicrobial dressings will dominate with a 44.0% market share, while malignant fungating wounds will lead the indication segment with a 40.0% share.